Bryan Johnson, the founder of the Don't Die movement, is all set to revolutionize food safety with his latest initiative: ...

Prospective real world data evaluation of clinical outcomes in metastatic hormone sensitive prostate cancer (MHSPC) patients treated as part of triplet therapy with darolutamide: UK multicenter ...

In the same way that genome sequencing determines the genetic makeup of an organism, Bryan Johnson — the investor and founder ...

Efficacy and safety of disitamab vedotin combined with toripalimab as neoadjuvant treatment for patients with locally advanced muscle-invasive bladder cancer: A mono-institutional retrospective study.

Quantum-Si's next-gen protein sequencing tech and growth partnerships show promise, but high costs, financial risks, and ...

The AGBT meeting has begun in Marco Island, Florida and Julianna LeMieux is on the ground. Here, she shares the latest news from the first day.

Next-generation sequencing provides detailed insights into genetics ... Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into ...

Traditional screening methods rely on biochemical tests, such as tandem mass spectrometry, which detect metabolic imbalances in a newborn’s blood sample. However, this method can miss genetic ...

“Our approach to efficiently sequencing DNA is to not sequence DNA,” Kokoris told GEN, chuckling ... landmark NGS papers in November 2008—the first African genome, the first Asian genome ...

In the pursuit of understanding the pathogenic expression mechanisms of bacteria and the advancements in biofoundry ...

A critically endangered new species of killifish sampled from an ancient forest in Kenya in 2017 and 2018 has been described ...

Quantum-Si aims to revolutionize protein sequencing amidst technological hurdles, uncertain advancements, and market ...